Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Histopathological profile of triple negative breast carcinomas seen in patients in National Hospital, Abuja over a 10-year period (January 2010-December 2019)

Tolulope A. Benye, Paul G. Jibrin, Ben I. Achusi, Friday G. Olah, Edmund J.C. Nwana
doi: https://doi.org/10.1101/2024.09.28.24314546
Tolulope A. Benye
1Federal Medical Centre, Jabi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tolulorimi{at}gmail.com
Paul G. Jibrin
2National Hospital, Abuja
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben I. Achusi
1Federal Medical Centre, Jabi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friday G. Olah
2National Hospital, Abuja
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edmund J.C. Nwana
3University of Abuja Teaching Hospital, Gwagwalada, Abuja
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Triple negative breast carcinoma (TNBC) cases in Africa and the black race which are most commonly seen among the reproductive age group are highly aggressive and have a high mortality rate. Based on its protein expression using immunohistochemical methods it does not express the hormone receptors (oestrogen and progesterone) and the human epidermal growth factor receptor 2 (HER2). As a result the only means of treating TNBC patients so far is by conventional chemotherapy +/- radiotherapy. Even then only 50.0 % of these patients will respond to the chemotherapy. Further studies which may help improve treatment and survival in these patients are important.

Objective This study is aimed at knowing the histopathological profile of TNBCs in Abuja with the expression of androgen receptor; an important marker in these patients.

Method Two hundred formalin-fixed paraffin embedded TNBC tissue blocks were selected for the study. The histological type and their respective histological grades (based on the Nottingham grading system) were noted from the haematoxylin and eosin(H&E) sections. Immunohistochemical staining was done using antibodies against androgen receptor (Biocare) and CK5/6 (Invitrogen) with in-house controls. The androgen receptor and CK5/6 expressions were analysed using a semi-quantitative scoring method: - A tumour was considered positive for LAR if ≥ 1.0 % of tumour cell nuclei were staining and positive for CK5/6 if ≥10.0 % of tumour cells had membrane staining. Other biographic data like tumour size, presence or absence of lymphovascular permeation were also analysed. Correlation between the histological types and grades were also done using SPSS version 21 statistical package.

Results The 30-49 age group had the highest frequency of TNBC. The commonest histological type seen among TNBCs is Invasive carcinoma; NST at 93.0%. The most frequent histological grade is grade 2 at 56.0 %. The androgen receptor subtype constituted 19.0 %. The basal subtype formed 28.5 % of the total sample size. There was no significant correlation between the histological type and grade of TNBC. 73.3% of the patients had tumour size of pT1 and pT2.

Conclusion This study shows that the percentage of androgen positive cases among triple negative breast carcinomas is significant enough to warrant routine luminal AR testing for TNBCs. Furthermore, this study has shown that the most frequent histological type is Invasive carcinoma; Non-specific type (NST) regardless of the molecular subtype and presence or absence of lympho-vascular permeation. It has also shown that the most frequent histological grade seen among patients with TNBCs is Grade 2.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of National Hospital, Abuja gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 30, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Histopathological profile of triple negative breast carcinomas seen in patients in National Hospital, Abuja over a 10-year period (January 2010-December 2019)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Histopathological profile of triple negative breast carcinomas seen in patients in National Hospital, Abuja over a 10-year period (January 2010-December 2019)
Tolulope A. Benye, Paul G. Jibrin, Ben I. Achusi, Friday G. Olah, Edmund J.C. Nwana
medRxiv 2024.09.28.24314546; doi: https://doi.org/10.1101/2024.09.28.24314546
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Histopathological profile of triple negative breast carcinomas seen in patients in National Hospital, Abuja over a 10-year period (January 2010-December 2019)
Tolulope A. Benye, Paul G. Jibrin, Ben I. Achusi, Friday G. Olah, Edmund J.C. Nwana
medRxiv 2024.09.28.24314546; doi: https://doi.org/10.1101/2024.09.28.24314546

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3310)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13396)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5171)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3282)
  • Health Policy (1144)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1022)
  • Infectious Diseases (except HIV/AIDS) (14649)
  • Intensive Care and Critical Care Medicine (914)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4945)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (796)
  • Oncology (2528)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (546)
  • Pediatrics (1304)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7524)
  • Radiology and Imaging (1713)
  • Rehabilitation Medicine and Physical Therapy (1017)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)